The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mongini, P. K.
Right arrow Articles by Dalton, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mongini, P. K.
Right arrow Articles by Dalton, J. P.

The Journal of Immunology, Vol 146, Issue 6 1791-1800, Copyright © 1991 by American Association of Immunologists


ARTICLES

Affinity requirements for induction of sequential phases of human B cell activation by membrane IgM-cross-linking ligands

PK Mongini, CA Blessinger and JP Dalton
Institute of Molecular Immunology, Hospital for Joint Diseases, New York, NY 10003.

The affinity of Ag interaction with a B cell's membrane IgM (mIgM) receptors has long been considered to play a critical role in the in vivo clonal selection of B lymphocytes. This study has examined a possible basis for this affinity selection at the level of Ag induction of sequential B cell activation phenomena, i.e., elevated membrane class II MHC expression (G0* excitation), G1 entry, and S phase entry. Functional experiments with model bivalent Ag, i.e., a group of murine mAb of diverse intrinsic binding affinities for human IgM, revealed that the minimal affinity requisites for inducing the above phenomena vary significantly. At a ligand concentration of 100 micrograms/ml, the induction of increased class II MHC expression, G1 entry, and S phase had minimal affinity thresholds of Ka approximately 0.2 to 2 x 10(6) M- 1; approximately 7 x 10(6) M-1; and approximately 1 x 10(8) M-1, respectively. Pulsing studies revealed that whereas high affinity ligand was essential at later periods in the prolonged (greater than 24 h) signaling period that leads to S phase entry, mAb with significantly lower affinity were competent at signaling during the first 24 h. Because all but the lowest affinity ligand (Ka = 2 x 10(5) M-1) could effectively modulate mIgM, and furthermore, because B cells show a substantial increase in surface area during activation, it appears likely that one factor contributing to the higher affinity requirements for induction of late activation phenomena is a progressive decrease in the density of mIgM on the responsive B cells. These studies suggest that whereas only a small proportion of B cells, i.e., those with relatively high affinity for an antigenic epitope, will be triggered to clonally expand on encountering a paucivalent Ag in the absence of T cell help, a much wider spectrum of the B cell repertoire will be triggered to a state of partial activation. How the presence of ancillary T cells and cytokines may facilitate the full clonal expansion of these latter cells is discussed.


This article has been cited by other articles:


Home page
J. Exp. Med.Home page
D. Paus, T. G. Phan, T. D. Chan, S. Gardam, A. Basten, and R. Brink
Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation
J. Exp. Med., April 17, 2006; 203(4): 1081 - 1091.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. K. A. Mongini, A. E. Jackson, S. Tolani, R. J. Fattah, and J. K. Inman
Role of Complement-Binding CD21/CD19/CD81 in Enhancing Human B Cell Protection from Fas-Mediated Apoptosis
J. Immunol., November 15, 2003; 171(10): 5244 - 5254.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. K.A. Mongini, Q. Liu, M. A. Vilensky, P. F. Highet, and J. K. Inman
Evidence for an Upper Affinity Threshold for Anti-IgM-Induced Apoptosis in a Human B-Cell Lymphoma
Blood, November 15, 1998; 92(10): 3756 - 3771.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
V. Kouskoff, S. Famiglietti, G. Lacaud, P. Lang, J. E. Rider, B. K. Kay, J. C. Cambier, and D. Nemazee
Antigens Varying in Affinity for the B Cell Receptor Induce Differential B Lymphocyte Responses
J. Exp. Med., October 19, 1998; 188(8): 1453 - 1464.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Taga, K. Carlier, Z. Mishal, C. Capoulade, M. Mangeney, Y. Lecluse, D. Coulaud, C. Tetaud, L. L. Pritchard, T. Tursz, et al.
Intracellular Signaling Events in CD77-Mediated Apoptosis of Burkitt's Lymphoma Cells
Blood, October 1, 1997; 90(7): 2757 - 2767.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.